Form 483

Farmaqro, S.A. de C.V. Form 483, 2016-07-29

FDA issued a Form 483 to Farmaqro, S.A. de C.V. on 2016-07-29 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Farmaqro, S.A. de C.V. · Santiago De Queretaro, Mexico · Issued July 29, 2016

Overview

  • 4 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

29 Jul 2016
21 CFR 211.100(a)

Absence of Written Procedures

Cited by Maria P Kelly-Doggett

29 Jul 2016
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Maria P Kelly-Doggett

29 Jul 2016
21 CFR 211.160(b)(4)

Calibration - at intervals, written program, remedial action

Cited by Maria P Kelly-Doggett

29 Jul 2016
21 CFR 211.84(d)(2)

Component identification test

Cited by Maria P Kelly-Doggett

Inspected site

FSFarmaqro, S.A. de C.V.Santiago De Queretaro, Mexico

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)(4)Cited across public-safe Form 483 observations1x
21 CFR 211.84(d)(2)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 4 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere